Search

everythinglearnresearchcommunity

for

Search:↓

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Different methods accurately measure Finasteride in medicines and body fluids.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The compound was successfully made and shows potential for treating prostate cancer.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Finasteride can slow hair loss and promote growth in postmenopausal women.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

SHBG may be a useful early indicator and treatment target for PCOS.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Certain extracts from Curcuma aeruginosa Roxb. and germacrone can boost the skin's absorption of minoxidil, a hair growth promoter, making it more effective.

ACBP is essential for healthy skin and fur by maintaining the skin's barrier function.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Smaller finasteride particles increase effectiveness in treating hair loss.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.